SciClone Pharmaceuticals
SciClone Pharmaceuticals is a specialty pharmaceutical company that focuses on developing and marketing therapies for oncology, infectious diseases, and cardiovascular disorders, primarily in China, the United States, and Hong Kong. Its lead product, ZADAXIN, is utilized for the treatment of hepatitis B and C, certain cancers, and as an immune system enhancer, with ongoing development for sepsis treatment. The company also offers a range of other products, including DC Bead, an approved treatment for liver cancer, and ondansetron RapidFilm, which addresses chemotherapy-induced nausea and vomiting. SciClone markets these products through various distribution channels and has established partnerships to promote specific therapies like Angiomax and Cleviprex. Founded in 1989 and headquartered in Foster City, California, SciClone remains committed to addressing unmet medical needs in rapidly growing therapeutic areas.
Ability Pharmaceuticals, S.L. is a clinical stage biopharmaceutical company based in Barcelona, Spain, dedicated to the discovery and development of human therapeutics for cancer and other unmet medical needs. The company specializes in creating Lipid Analogue Therapeutics, a novel class of small molecules designed to be administered orally. Its primary focus is on developing treatments for lung, pancreatic, and gynecological cancers. The development pipeline includes ABTL0812, which targets the Akt/mTOR signaling pathways, and ABTL0815, currently in preclinical characterization. Ability Pharmaceuticals develops its drug candidates up to clinical proof of concept before out-licensing them to pharmaceutical companies for further development. Founded in 2009, the company was formerly known as AB Therapeutics, S.L. and changed its name in September 2012.
NovaMed Pharmaceuticals (诺凡麦医药) is a Chinese group based on virtual integration. It is focused on complete business functions such as sales and marketing, register, circulation, manufacture, and R&D. NovaMed Pharmaceuticals was founded by senior management personnel in transnational pharmaceutical companies. The founders are professionals with broad social networks and domestic market knowledge.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.